8-K 1 eightk.txt EIGHTK.TXT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2002 AMERICAN BIO MEDICA CORPORATION ------------------------------------------------- (Exact Name of Registrant as Specified in its Charter) New York 0-28666 14-1702188 ---------------------------- ------------ ---------------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification Number) 122 Smith Road, Kinderhook, NY 12106 --------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (800) 227-1243 ITEM 5. OTHER EVENTS On February 6, 2002, the Board of Directors of the registrant accepted the resignation of Robert L. Aromando as President and Chief Executive Officer. Aromando will remain a Director of the registrant. Gerald Moore, the registrant's current Chairman of the Board of Directors, was appointed to the position of President and Chief Executive Officer of the registrant. Moore also remains the registrant's Chairman of the Board of Directors. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits. The following exhibits are filed with this report on Form 8-K: 99.1 American Bio Medica Corporation press release dated February 7, 2002 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMERICAN BIO MEDICA CORPORATION (Registrant) Dated: February 7, 2002 By: /s/ Keith E. Palmer ---------------------------- Keith E. Palmer Chief Financial Officer Exhibit Index Exhibit No. Description Page No. ----------- ----------- -------- 99.1 American Bio Medica Corporation press 5 release dated February 7, 2002